Moderna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
A ‘sell-the-news reaction’? The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years.
A ‘sell-the-news reaction’? The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years. This story matters for Finance & Markets readers tracking broker. Reported by marketwatch.com. Read the full original at the source link below.
Originally reported by marketwatch.com. BrokerNews.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily broker signal